Page 356 - The Case Lab Book
P. 356
Blackthorn immediately called an extraordinary board
meeting where he informed the board that their new drug
would statistically result in the deaths of young children
some five years after its introduction.
Proxydychromil was due to be launched within the month so
a decision on the way forward had to be arrived at.
Profile: Board Memebers
Meet The Phissons’ Board
Click on a button in the organisational chart to view the
member’s profile.
The executive profile will then give access to their rationale
for their position on the issue of PROXYDYCHROMIL.
